Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for determining responsiveness to an anti-CD47 agent

Methods for determining responsiveness to an anti-CD47 agent

US Patent 9957576 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD47 targeted therapies for the treatment of infectious disease2025
Non-genotoxic conditioning regimen for stem cell transplantation2025
Systems and methods for end-to-end consumer lending and financing solutions for 2025
Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
Methods for achieving therapeutically effective doses of anti-CD47 agents2025
Methods for treating myeloma by achieving therapeutically effective doses of ant2025
Engraftment of stem cells with a combination of an agent that targets stem cells2025
Dosing parameters for CD47 targeting therapies to hematologic malignancies2025
High affinity SIRP-alpha reagents and methods of using2025
Methods for manipulating phagocytosis mediated by CD472024
Targeting aneurysm disease by modulating phagocytosis pathways2024